Safety and efficacy of tocilizumab in critically ill patients with COVID-19: an observational study

Safety and efficacy of tocilizumab in critically ill patients with COVID-19: an observational study

Abstract Background Since the coronavirus disease 2019 (COVID-19) outbreak has rapidly propagated with a high mortality rate, it is currently considered a global emergency. Worldwide, the number of patients with severe acute respiratory syndrome caused by coronavirus 2 is steadily rising. Pneumonia,...

Full description

Bibliographic Details
Main Authors: Ghada A. Youssef, Khalid M. Wagih, Hossam M. Abdel Hamid
Format: Article
Language:English
Published: SpringerOpen 2023-09-01
Series:The Egyptian Journal of Bronchology
Subjects:
Safety efficacy
Tocilizumab critically
COVID-19
Observational study
Online Access:https://doi.org/10.1186/s43168-023-00220-7

Internet

https://doi.org/10.1186/s43168-023-00220-7

Similar Items